Press release
Acute Respiratory Distress Syndrome (ARDS) Therapeutics Market Is Likely to Experience a Tremendous Growth by 2029
The global acute respiratory distress syndrome therapeutics market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2023-2029). A number of government information initiatives are underway to educate the public about the various diagnoses and treatments accessible. Several items with superior powers have been launched by major market businesses. Hospitals/Clinics are well equipped with advanced technological equipment for surgical procedures and improved treatments and the hospital segment is witnessing rapid growth, owing to the growing number of hospital admission with the ARDS therapeutics, the increasing number of patient pools, and the launch of new products by the market players are expected to continue over the forecast period, and thus, driving growth in the segment.The increasing number of hospitals by private players is also expected to propel the growth of the market. For instance, in April 2022, the Food and Drug Administration (FDA) approved Direct Biologics to proceed with a Landmark Phase 3 clinical trial using its investigation EV Drug ExoFlow to treat acute respiratory distress syndrome (ARDS) therapeutic. For instance, in January 2022, Veru declared that Sabizabulin has been given a fast-track designation by the FDA for the treatment of hospitalized COVID-19 patients who are at high risk of developing acute respiratory distress syndrome.
To Request a Sample of our Report on Acute Respiratory Distress Syndrome (ARDS) Therapeutics Market: https://www.omrglobal.com/request-sample/acute-respiratory-distress-syndrome-ards-therapeutics-market
Market Coverage
• The market number available for - 2023-2029
• Base year- 2022
• Forecast period- 2023-2029
Segment Covered-
· By Type
· By Drug Class
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- Therabron Therapeutics, Inc, Serendex Pharmaceuticals A/S, Silence Therapeutics Plc, Histocell S.L., Altor BioScience Corporation, and others.
Acute Respiratory Distress Syndrome Therapeutics Market Report Segment
By Type
• Methylprednisolone
• Hydrocortisone
• Calf Pulmonary Surfactant for Injection
• Others
By Drug Class
• Corticosteroids
• Antimicrobials
• Bronchodilators
• Other Medications
By Application
• In-Patient
• Out-Patient
A full Report of Acute Respiratory Distress Syndrome (ARDS) Therapeutics Marketis Available @ https://www.omrglobal.com/industry-reports/acute-respiratory-distress-syndrome-ards-therapeutics-market
Acute respiratory distress syndrome therapeutics Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
• Latin America
• Middle East and Africa
Company Profiles
· Altor BioScience Corp.
· Athersys, Inc
· Faron Pharmaceuticals Oy
· FirstString Research, Inc.
· FRESENIUS SE & CO. KGAA
· GETINGE AB
· GILEAD SCIENCES INC.
· GlaxoSmithKline Plc
· Histocell S.L.
· Medtronic, Inc.
· NIPRO and PFIZER INC.
· Phylogica Ltd.
· Serendex Pharmaceuticals A/S
· Silence Therapeutics plc
· Terumo Corp.
· Therabron Therapeutics, Inc.
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/acute-respiratory-distress-syndrome-ards-therapeutics-market
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%eb%86%80%eb%9d%bc%ec%9a%b4-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%aa%a9%ea%b2%a9%ed%95%a0-%ec%85%80%eb%a3%b0%eb%9f%ac-iot-%ea%b2%8c%ec%9d%b4%ed%8a%b8%ec%9b%a8%ec%9d%b4/403366/
https://monblogapple.com/2023/03/20/taux-de-croissance-lent-du-marche-des-gaz-et-equipements-medicaux-prevu-dici-2023-2029/
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/plasminogen-activator-inhibitor-market-%ec%a0%84%ec%84%b8%ea%b3%84-%ec%82%b0%ec%97%85-%eb%b6%84%ec%84%9d-%eb%af%b8%eb%9e%98-%ec%88%98%ec%9a%94-%eb%b0%8f-2029-%eb%85%84%ea%b9%8c%ec%a7%80/39688/
https://www.diario-ya.com/regionales/%e5%88%b0-2029-%e5%b9%b4%e5%96%ae%e5%90%91%e7%b6%b2%e7%b5%a1%e5%ae%89%e5%85%a8%e7%94%a2%e5%93%81%e5%b8%82%e5%a0%b4%e5%b0%87%e5%bf%ab%e9%80%9f%e5%a2%9e%e9%95%b7/528077/
https://revistaeconomiasocial.com/2023/03/20/el-mercado-de-productos-de-seguridad-de-red-unidireccional-significara-un-fuerte-crecimiento-para-2023-2029/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Respiratory Distress Syndrome (ARDS) Therapeutics Market Is Likely to Experience a Tremendous Growth by 2029 here
News-ID: 2984725 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…